Menarini Biotech
Thoralf Keller is an experienced leader in the biotechnology industry, currently serving as the General Manager (CEO) at Menarini Biotech since September 2017. Prior to this role, Thoralf held key positions at Juno Therapeutics, Inc. as Senior Director of Clinical Manufacturing and Process Development, and at Fresenius Biotech GmbH as Senior Director of Commercial Manufacturing. With a strong background in quality assurance and manufacturing processes gained from roles at Biogen and earlier positions in companies like Trionpharma and Sandoz, Thoralf has developed extensive expertise in biopharmaceutical production. Thoralf Keller holds a Master's degree in Biotechnology from the Technical University of Munich, completed in 1991.
This person is not in any teams
Menarini Biotech
4 followers
Menarini Biotech (“MBH”) is a fast-growing, agile, fully integrated CDMO for biologics located in the greater Rome area, Italy. Established in 2003, Menarini Biotech’s mission is to provide fast and efficient, yet very customer-centric, world-class, high-quality, services for biotech companies from preclinical development to GMP manufacturing (Mammalian and Microbial) up to BSL-2. These include CHO cell line development and analytical development for standard and non-standard mAbs, and new molecular formats, e.g. bispecifics, ADCs, fusion proteins. Our Quality System complies with AIFA/EU GMP requirements.